Addition of Spironolactone in Patients With Resistant Arterial Hypertension (ASPIRANT) Full Text
Hypertension,  Clinical Article

Václavík J et al. – Spironolactone is an effective drug for lowering systolic blood pressure (BP) in patients with resistant arterial hypertension.

Methods
  • Double–blind, placebo–controlled, multicenter trial
  • Patients with office systolic BP >140 mm Hg or diastolic BP >90 mm Hg despite treatment with at least 3 antihypertensive drugs, including a diuretic, were enrolled
  • 117 patients were randomly assigned to receive spironolactone (n=59) or a placebo (n=58) as an add–on to their antihypertensive medication, by the method of simple randomization.
  • Analyses were done with 111 patients (55 in the spironolactone and 56 in the placebo groups).

Results
  • At 8 weeks, the primary end points, a difference in mean fall of BP on daytime ambulatory BP monitoring (ABPM), between the groups was –5.4 mm Hg (95% CI –10.0; –0.8) for systolic BP (P=0.024) and –1.0 mm Hg (95% CI –4.0; 2.0) for diastolic BP (P=0.358).
  • The APBM nighttime systolic, 24–hour ABPM systolic, and office systolic BP values were significantly decreased by spironolactone (difference of –8.6, –9.8, and –6.5 mm Hg; P=0.011, 0.004, and 0.011), whereas the fall of the respective diastolic BP values was not significant (–3.0, –1.0, and –2.5 mm Hg; P=0.079, 0.405, and 0.079).
  • The adverse events in both groups were comparable.

Please login or register to follow this author.
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Nephrology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Nephrology Articles

1 Muscle mass and chronic kidney disease Yale School of Medicine News, November 13, 2014

2 Metformin in chronic kidney disease: Time for a rethink Peritoneal Dialysis International, July 9, 2014    Clinical Article

3 Effects of tea intake on blood pressure: A meta-analysis of 21 randomized controlled trials JACC - Journal of the American College of Cardiology, October 22, 2014    Clinical Article

4 Associations of sugar and artificially sweetened soda and chronic kidney disease: A systematic review and meta-analysis Nephrology, September 26, 2014    Evidence Based Medicine    Review Article

5 Tonsillectomy for IgA nephropathy: A meta-analysis American Journal of Kidney Diseases, October 29, 2014    Evidence Based Medicine

6 Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American college of physicians Annals of Internal Medicine, November 11, 2014    Evidence Based Medicine    Clinical Article

7 Hypertension in the United States, 1999 to 2012 Circulation, November 6, 2014    Clinical Article

8 Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD Clinical Journal of the American Society of Nephrology, November 13, 2014    Clinical Article

9 Erythropoietin and resistant hypertension in CKD Seminars in Nephrology, November 25, 2014    Clinical Article

10 Sudden cardiac death in end stage renal disease: Unlocking the mystery Full Text Journal of Nephrology, November 13, 2014    Free full text    Review Article

11 The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): A prospective randomized controlled trial Critical Care, January 13, 2014    Clinical Article

12 Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis Canadian Medical Association Journal, August 12, 2013    Evidence Based Medicine    Review Article    Clinical Article

13 Drug-induced reduction in albuminuria is associated with subsequent renoprotection: A meta-analysis Journal of the American Society of Nephrology, November 26, 2014    Evidence Based Medicine    Clinical Article

14 Effects of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: A Phase IIb, randomized study Full Text BMC Nephrology, November 19, 2014    Free full text    Clinical Article

15 A randomized comparison of 1-h sodium bicarbonate hydration versus standard peri-procedural saline hydration in patients with chronic kidney disease undergoing intravenous contrast-enhanced computerized tomography Nephrology Dialysis Transplantation, May 5, 2014    Clinical Article

16 Maintaining safety in the dialysis facility Clinical Journal of the American Society of Nephrology, November 12, 2014    Clinical Article

17 Gastrointestinal inhibition of sodium-hydrogen exchanger 3 reduces phosphorus absorption and protects against vascular calcification in CKD Journal of the American Society of Nephrology, November 19, 2014    Clinical Article

18 Pathophysiology and treatment of resistant hypertension: The role of aldosterone and amiloride-sensitive sodium channels Seminars in Nephrology, November 24, 2014    Review Article

19 Acute kidney injury and prognosis after cardiopulmonary bypass: A meta-analysis of cohort studies American Journal of Kidney Diseases, November 7, 2014    Evidence Based Medicine    Clinical Article
Exclusive Author Commentary

20 Role of aldosterone blockade in resistant hypertension Seminars in Nephrology, October 30, 2014    Review Article

Indexed Journals in Nephrology: Kidney International, Hemodialysis International, Nephrology Dialysis Transplantationmore